NCT00680160View on ClinicalTrials.gov

Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME I)

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

May 9, 2007

Study Completion Date

May 9, 2007

Conditions
Onychomycosis
Interventions
DRUG

AN2690

AN2690 7.5% Solution, once daily for 28 days

Trial Locations (1)

77802

J&S Studies, Bryan

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00680160 - Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME I) | Biotech Hunter | Biotech Hunter